Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial

Michael Mullen, Xu Yu Jin, Anne Child, A Graham Stuart, Matthew Dodd, José Antonio Aragon-Martin, David Gaze, Anatoli Kiotsekoglou, Li Yuan, Jiangting Hu, Claire Foley, Laura Van Dyck, Rosemary Knight, Tim Clayton, Lorna Swan, John D R Thomson, Guliz Erdem, David Crossman, Marcus Flather, AIMS Investigators

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science